Osteoporosis is a growing concern among the people of the nation. It has been recently revealed that as many as 200, 000 patients suffering from the disease might be able to have an easy access to the drugs that might help them fight the disease, and increase the density of their bones. This is because there has been an expansion ordered in the pharmaceutical Benefits Scheme listing for Fosamax, the osteoporosis treatment.

Osteoporosis is a very deteriorative disease and it tends to make the bones reduce the mineral content, which makes them weak and prone to fractures. There is need for people to take care of their bone health, before it is too late. Osteoporosis tends to affect people at an early age these days, and this is the reason people need to take enough calcium supplements so that their bodies can have effective nutrition and stay away from possible fractures.

"This is a significant move forward in terms of equitable access to medication "We would see the number of hospital cases drop for hip and spine fractures and if people were employed they would not have to take time off work", revealed Medical director at Osteoporosis Australia Peter Ebeling.

This new ruling shall be able to help many of the osteoporosis patients, as they would tend to have stronger bones, with the help of these medicines, and that too at affordable rates.

Because of the high costs of the drugs, many people suffering from the disease have not been able to get treatment. This new move shall definitely help people in getting treatment, and stay away from the disease, which can lead to horrible fractures. This move shall particularly help the pensioners, as it would tend to give them the freedom of availing treatment for their condition, without having to spend oodles of money on it.